Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kinetic Concepts to sell NeutroPhase solution:

This article was originally published in Clinica

Executive Summary

Kinetic Concepts (San Antonio) has secured exclusive worldwide rights to commercialise a wound disinfectant developed by Novabay Pharmaceuticals. NeutroPhase is a diluted solution of hypochlorous acid in saline with broad-spectrum antimicrobial properties, developed to kill a wide range of bacteria. The company claim that the solution has been shown not to harm cells, and is rapidly effective against common wound pathogens at concentrations that are 200 times lower than the level toxic to human cells. Kinetic plans to market NeutroPhase as a stand alone product for cleansing wounds, and also in combination with its own proprietary VAC (Vacuum-Assisted Closure) Instill wound-healing therapy.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048913

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel